Journals / Mucosa / 2020 / Cilt: 3 - Sayı: 2

Injectable platelet-rich fibrin: a new material in medicine and dentistry

Enjekte edilebilen trombositten zengin fibrin: Tıpta ve diş hekimliğinde yeni bir materyal

Journal
Mucosa
Pages
27–33
Publication Date
2020-06-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is not difficult to predict that this completely autogenous blood concentrate, which can be used with minimally invasive methods and has many indications, will be used very widely in the future.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Blood concentrates have been used in medicine and dentistry for many years as a wide variety of products.
📊
Key Findings & Data:However, injectable platelet-rich fibrin (i-PRF), an autogenous blood concentrate found three years ago, is noteworthy.
💡
Conclusion & Impact:It is not difficult to predict that this completely autogenous blood concentrate, which can be used with minimally invasive methods and has many indications, will be used very widely in the future.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:trombositten zengin fibrin · enjekte edilebilir trombositten zengin fibrin · trombositten zengin plazma

Abstract

Blood concentrates have been used in medicine and dentistry for many years as a wide variety of products. However, injectable platelet-rich fibrin (i-PRF), an autogenous blood concentrate found three years ago, is noteworthy. It is not difficult to predict that this completely autogenous blood concentrate, which can be used with minimally invasive methods and has many indications, will be used very widely in the future.

Özet

Kan konsantreleri tıpta ve diş hekimliğinde uzun yıllardır çok çeşitli ürünler olarak kullanılmaktadır. Buna rağmen, üç yıl önce bulunan bir otojen kan konsantresi olan enjekte edilebilen trombositten zengin fibrin (i-PRF) dikkati çekmektedir. Minimal invazif yöntemlerle kullanılabilen ve şimdiden birçok endikasyonu olan bu tamamen otojen kan konsantresinin gelecekte çok yaygın kullanılacağını tahmin etmek güç değil.

🔖

Cite This Article

ÖZSAĞIR, Z. B., TUNALI, M. (2020). Injectable platelet-rich fibrin: a new material in medicine and dentistry. Mucosa, Cilt: 3 - Sayı: 2, 27–33. https://ajindex.com/articles/840030

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Kingsley CS. Blood coagulation; evidence of an antagonist to factor VI in platelet-rich human plasma. Nature 1954;173:723-4
  2. Anfossi G, Trovati M, Mularoni E, Massucco P, Calcamuggi G, Emanuelli G. Influence of propranolol on platelet aggregation and thromboxane B2 production from platelet-rich plasma and whole blood. Prostaglandins, leukotrienes and essential fatty acids 1989;36:1-7
  3. Fijnheer R, Pietersz R, De Korte D, et al. Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods. Transfusion 1990;30:634-8
  4. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638-46
  5. Borzini P, Balbo V, Mazzucco L. Platelet concentrates for topical use: bedside device and blood transfusion technology. Quality and versatility. Curr Pharm Biotechnol 2012; 13:1138-44
  6. Jameson CA. Autologous platelet concentrate for the production of platelet gel. Laboratory Medicine 2007;38:39-42
  7. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004;62:489-96
  8. Reinke JM, Sorg H. Wound repair and regeneration. Eur Surg Res 2012;49:35-43
  9. Freire MO, Van Dyke TE. Natural resolution of inflammation. Periodontology 2000 2013;63:149-64
  10. Kasnak G, Tunali M, Firatli HE. Geçmişten günümüze kan kaynaklı ürünler ve trombositten zengin fibrinler. Turkiye Klinikleri J Periodontol-Special Topics 2017;3:109-12
  11. Dohan DM, Choukroun J, Diss A, et al. Plateletrich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e37-e44
  12. Dohan Ehrenfest DM, Rasmusson L, Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte and platelet-rich fibrin (L-PRF). Trends Biotechnol 2009;27:158-67
  13. Dohan Ehrenfest DM, Del Corso M, Diss A, Mouhyi J, Charrier J-B. Three-dimensional architecture and cell composition of a Choukroun’s platelet rich fibrin clot and membrane. J Periodontol 2010;81:546-55
  14. Choukroun J, Diss A, Simonpieri A, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e56-60
  15. O’Connell SM. Safety issues associated with platelet-r